CDC-RFA-CK22-2201.pdf

PDF 753 KB Posted

Attached to
Reducing the Tuberculosis Burden in U.S. Bound Populations from the Philippines
Opportunity number
CDC-RFA-CK22-2201
Issued by

About this file

CDC-RFA-CK22-2201.pdf

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Centers for Disease Control and Prevention

National Center for Emerging and Zoonotic Infectious Diseases

Reducing the Tuberculosis Burden in U.S. Bound Populations from the Philippines

CDC-RFA-CK22-2201

Application Due Date: May 2, 2022

Table of Contents A. Funding Opportunity Description

B. Award Information

C. Eligibility Information

D. Application and Submission Information

E. Review and Selection Process

F. Award Administration Information

G. Agency Contacts

H. Other Information

I. Glossary

Part I. Overview Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Subscribe" button link to ensure they receive notifications of any changes to CDC-RFA- CK22-2201. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry (ATSDR) B. Notice of Funding Opportunity (NOFO) Title:

Reducing the Tuberculosis Burden in U.S. Bound Populations from the Philippines C. Announcement Type: New - Type 1:

This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52- 2.pdf. Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr- 46/index.html (See section 45 CFR 46.102(d)).

New - Type 1

D. Agency Notice of Funding Opportunity Number:

CDC-RFA-CK22-2201

E. Assistance Listings Number:

93.318 F. Dates:

1. Due Date for Letter of Intent (LOI):

N/A https://www.grants.gov/ https://www.grants.gov/ https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html

2. Due Date for Applications:

May 2, 2022 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov.

3. Due Date for Informational Conference Call:

N/A

G. Executive Summary:

1. Summary Paragraph CDC's Division of Global Migration and Quarantine (DGMQ) is focused on improving the health among immigrants (including Special Immigrant Visa holders), asylees, parolees, survivors of victims of torture, human trafficking victims, and refugees through public health partnerships, science, and response. The purpose of this program is to implement strategies to reduce the incidence of TB in the Philippines and to reduce the tuberculosis burden in US bound populations from the Philippines. The aim is to engage public health officials to develop and implement a system to identify persons at risk of TB infection; provide training support to regions with elevated rates of TB and drug-resistant TB; build the capacity of local jurisdictions to treat and care for individuals with TB; and develop and implement trainings for public health partners to increase knowledge and promote TB identification, diagnosis, and treatment best practices. Measurable outcomes of the program will be in alignment with at least one of the following performance goal(s) for the National Center for Emerging and Zoonotic Infectious Diseases: Protect Americans from Infectious Diseases. This announcement is only for non-research activities supported by CDC.

a. Eligible Applicants:

Open Competition

b. Funding Instrument Type:

CA (Cooperative Agreement)

c. Approximate Number of Awards

d. Total Period of Performance Funding:

$5,000,000

e. Average One Year Award Amount:

$1,000,000

f. Total Period of Performance Length:

g. Estimated Award Date:

August 30, 2022

h. Cost Sharing and / or Matching Requirements:

No Part II. Full Text A. Funding Opportunity Description

1. Background

a. Overview https://www.grants.gov/

Immigrant and refugee applicants for US immigration are required to undergo a medical examination pursuant to section 232 of the Immigration and Nationality Act (INA) (8 U.S.C.

1222). Sections 212(a)(1)(8 U.S.C. 1182) and 232 of the INA, and section 325 of the Public Health Service (PHS) Act (42 U.S.C. 252) grant the Secretary of Health and Human Services (HHS) authority to publish regulations that establish the requirements for, and components of, the medical examination of aliens. Title 42 of the Code of Federal Regulations Part 34, entitled Medical Examination of Aliens, also define the communicable diseases of public health significance that make aliens inadmissible to the United States and provide that all medical examinations shall be carried out in accordance with the Technical Instructions for physicians conducting the medical examination of aliens as may be issued by the Director of Quarantine.

This NOFO is intended to implement strategies to reduce the incidence of TB in the Philippines and to reduce the tuberculosis burden in US bound populations from the Philippines in order to reduce the burden needed to be detected by US panel physicians. The aim is to engage public health officials to develop and implement a system to identify persons at risk of TB infection;

provide training support to regions with elevated rates of TB and drug-resistant TB; build the capacity of local jurisdictions to treat and care for individuals with TB; and develop and implement trainings for public health partners to increase knowledge and promote TB identification, diagnosis, and treatment best practices.

b. Statutory Authorities This program is authorized under Public Health Service Act sections 301(a) (42 U.S.C. 241(a));

317(k)(2) (42 U.S.C. 247b(k)(2)), and 307 (42 U.S.C. 242l).

c. Healthy People 2030 This program addresses the “Healthy People 2030” focus area(s) of Global Health (https://health.gov/healthypeople).

d. Other National Public Health Priorities and Strategies N/A

e. Relevant Work N/A

2. CDC Project Description

a. Approach

Bold indicates period of performance outcome.

Strategies and Activities

Short-term Outcome

Intermediate Outcomes

Long-Term Outcomes

- Provide onsite training support to regions in the Philippines which has elevated rates of Tuberculosis and drug resistant Tuberculosis

- Improve education and knowledge of Tuberculosis burden for local ministries of health in the Philippines

- Increase accessibility of adequate

- Increase detection and treatment of TB cases in the Region(s)

- Increase or improve

- Decrease importation of Tuberculosis

Decreased incidence of infectious Tuberculosis in https://health.gov/healthypeople https://health.gov/healthypeople/objectives-and-data/browse-objectives/global-health

- Work directly with public health officials and ministry of health partners to develop and implement a system, strategy, and plan to detect/identify those infected and/or at risk of infection of Tuberculosis

- Develop the organizational capacity to provide training, education, and support to local health jurisdictions

- Develop and implement specific trainings to improve knowledge and promote best practices to partners and health jurisdictions identifying, diagnosing and treating those affected with Tuberculosis

Tuberculosis medication and testing equipment/supplies

- Improve quality and standards of care for individuals being treated for infectious Tuberculosis

- Improve patient education of infectious Tuberculosis and importance of completing the course of antibiotics

- Improve knowledge of Multi-Drug Resistance (MDR) and Extensively Drug Resistant (XDR) Tuberculosis for patients and local ministries of health tracking for Tuberculosis detection

- Increase access to testing facilities and proper medication regimen to successfully treat infectious tuberculosis country and in US bound populations

- Improve efficiency of Tuberculosis detection and treatment for local ministries of health and the National Tuberculosis Program

-Reduce Tuberculosis in source population for US-bound populations

i. Purpose This NOFO is intended to implement strategies to reduce the incidence of TB in the Philippines and to reduce the tuberculosis burden in US bound populations from the Philippines. The aim is to engage public health officials to develop and implement a system to identify persons at risk of TB infection; provide training support to regions with elevated rates of TB and drug-resistant TB; build the capacity of local jurisdictions to treat and care for individuals with TB; and develop and implement trainings for public health partners to increase knowledge and promote TB identification, diagnosis, and treatment best practices.

ii. Outcomes Short-Term:

1. Improve education and knowledge of Tuberculosis burden for local ministries of health in the Philippines

2. Increase accessibility of adequate Tuberculosis medication and testing equipment/supplies

3. Improve quality and standards of care for individuals being treated for infectious Tuberculosis

Intermediate Outcomes:

1. Increase or improve tracking for Tuberculosis detection

2. Increase access to testing facilities and proper medication regimen to successfully treat infectious tuberculosis

Long-Term Outcomes:

1. Decrease importation of Tuberculosis into the United States

2. Improve efficiency of Tuberculosis detection and treatment for local ministries of health and the National Tuberculosis Program

3. Reduce Tuberculosis in source population for US-bound populations

iii. Strategies and Activities

1. Provide onsite training support to regions in the Philippines which has elevated rates of

Tuberculosis and drug resistant Tuberculosis

a. Create and implement onsite and remote trainings to assist regional jurisdictions with TB cases management

b. Provide trainings, workshops, etc. to diagnose, manage, and treat TB; specifically, medically drug-resistant TB

c. Provide on-site technical assistance to establish lab infrastructure for identifying

TB (MDR and XDR)

d. Provide on-site technical assistance for administering diagnostic testing, x-rays, and contact tracing of TB cases

2. Work directly with public health officials and ministry of health partners to develop and implement a system, strategy, and plan to detect/identify those infected and/or at risk of infection of Tuberculosis

a. Provide resources and training materials to increase technical expertise of TB surveillance/tracking systems

b. Work with local ministries of health to increase access to the necessary drugs and testing equipment to identify, manage, and treat tuberculosis

c. Procure supply of adequate doses of TB treatment medications to administer to patients in high incidence areas

d. Follow-up with patients and provide TB specific education throughout entire treatment course to ensure full completion

e. Work with governmental and non-governmental organization to follow-up TB suspects

f. Establish treatment sites and/or mobile clinics in rural areas where the TB burdens are higher to increase access to testing and treatment for TB

g. Ensure ministries of health and the national TB program are properly diagnosing, managing, and treating TB, specifically MDR and XDR TB.

3. Develop the organizational capacity to provide training, education, and support to local health jurisdictions

a. Host learning modules with trainings accessible to local health providers and staff on TB case management at the community level

b. Increase the number of well-trained staff by providing continuing education

c. Provide training to strengthen organizational capacity and build digital platform for virtual TB consultations

d. Create/develop/enhance a network for healthcare providers in the Philippines and facilitate communication between health entities with the goal of improving the diagnosing, management, and treatment of TB

e. Establish/Expand surveillance system to collect data on all TB cases

f. Establish mechanism to identify source of TB cases and implement referral system of outbound cases to the receiving countries

4. Develop and implement specific trainings to improve knowledge and promote best practices to partners and health jurisdictions identifying, diagnosing, and treating those affected with Tuberculosis

a. Expand outreach to improve advocacy, capacity building, and operational support for health entities that identify, diagnose, and treat tuberculosis cases

b. Create standard policies and procedures around complete, accurate medical recording for documenting care, clinical follow-up, early detection of complications, and health outcomes

c. Establish standard policies and procedures for healthcare provider interaction with patients

1. Collaborations

a. With other CDC projects and CDC-funded organizations:

The recipient is not required to collaborate with other CDC-funded organizations. A list of optional collaborations is noted below:

CDC Country Office in Philippines (if established)

b. With organizations not funded by CDC:

The recipient is expected to collaborate with organizations not funded by CDC. A list of optional collaborations is noted below:

Partnership with National Tuberculosis Program (NTP) Partnership with USAID Partnership with St Luke's Medical Center Extension Clinic Partnership with Department of State (DOS) – U.S. Embassy/Consular Section Local Ministries of Health Public Health Officials Local Health Organizations Private and Public Health Organizations

2. Target Populations Source communities of US Bound Populations From the Philippines

a. Health Disparities

The populations this NOFO will address are U.S. bound populations in the Philippines (immigrant visa applicants, non immigrant visa applicants, and refugees), many of which are living in areas with high burdens of infectious diseases including tuberculosis. This makes them a vulnerable population. By working to decrease their burdens of infectious diseases, this will help reduce health disparities among foreign born populations in the Philippines.

iv. Funding Strategy N/A

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy

Outcomes and Activities Indicators

1. Improve education and knowledge of

Tuberculosis burden for local ministries of health in the Philippines

# of regional trainings conducted

# of training attendees from each region

% of attendees that pass the posttest assessment

a. Provide trainings and workshops to diagnose, manage, and treat TB;

specifically, medically drug-resistant TB

# of trainings provided quarterly

# of MoH members trained quarterly

b. Provide on-site technical assistance to establish lab infrastructure for identifying TB (MDR and XDR)

# of on-site visits by technical consultants

# of labs established

c. Provide training to strengthen organizational capacity and build digital platform for virtual TB consultations

Digital platform for virtual TB consultations has been established

# of sites utilizing digital platform

2. Increase accessibility of adequate Tuberculosis medication and testing equipment/supplies

# of vendors/supplier relationships

# of procurement contracts

a. Provide on-site technical assistance for administering diagnostic testing, x-rays, and contact tracing of TB cases

# of identified TB cases of all forms

# of patients contacted to begin TB treatment

# of diagnostic testing performed

# of x-rays performed # of people in contact with

TB patients who began preventative therapy

b. Procure supply of adequate doses of TB treatment medications to administer to patients in high incidence areas

# amount of medication supply procured

# of doses to that can be administered

# of patients that have begun treatment

3. Improve quality and standards of care for individuals being treated for infectious Tuberculosis

# of staff that have been trained on proper bedside matter

% of MDR cases % XDR cases

a. Follow-up with patients and provide TB specific education throughout entire treatment course to ensure full completion

# of patients registered as TB patients

# of patients that have completed full treatment

b. Establish standard policies and procedures for healthcare provider interaction with patients

Implementation of policy and procedure manual

Training conducted on new policies

# of staff attendees of policy training

4. Increase or improve tracking for Tuberculosis detection

Procurement of information systems server

% of submitted facility reports

Average turnaround time of facility reporting

a. Work with governmental and non-governmental organization to follow-up TB suspects

Integration of monitoring tool

b. Establish/Expand surveillance system to collect data on all TB cases

# of facilities utilizing monitoring tool

# of facilities with access to information system server

5. Increase access to testing facilities and proper medication regimen to successfully treat infectious tuberculosis

# of testing facilities in each region

# of adequate labs available in each region

# of patients diagnosed at mobile clinics

# of patients treated at mobile clinics

a. Establish treatment sites and/or mobile clinics in rural areas where the TB burdens are higher to increase access to testing and treatment for TB

# of mobile clinics established

6. Decrease importation of Tuberculosis # of TB positive cases from inbound refugees/migrants

% of MDR cases % of XDR cases

a. Ensure ministries of health and the national TB program are properly diagnosing, managing, and treating TB, specifically MDR and XDR TB.

# of monthly reports received by MoH

# of monthly reports received by NTB

7. Improve efficiency of Tuberculosis detection and treatment for local ministries of health and the National Tuberculosis Program

Implementation of data management portal

The length of time between detection and receipt of treatment (If these data are available)

a. Create/develop/enhance a network for healthcare providers in the Philippines and facilitate communication between health entities with the goal of improving the diagnosing, management, and treatment of

TB

# of health care providers utilizing portal

8. Reduce Tuberculosis in source population for US-bound populations

Provide technical assistance and guidance to local health entities in the Philippines to properly diagnose, manage, and treat TB

# of TB cases identified in US bound populations

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How the applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant)

Plans for updating the Data Management Plan (DMP) as new pertinent information becomes available. If applicable, throughout the lifecycle of the project. Updates to DMP should be provided in annual progress reports. The DMP should provide a description of the data that will be produced using these NOFO funds; access to data;

data standards ensuring released data have documentation describing methods of collection, what the data represent, and data limitations; and archival and long-term data preservation plans. For more information about CDC’s policy on the DMP, see https://www.cdc.gov/grants/additional-requirements/ar-25.html.

Where the applicant chooses to, or is expected to, take on specific evaluation studies, the applicant should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, if applicable, within the first 6 months of award, as described in the Reporting Section of this NOFO.

For the proposed outcomes indicators listed above, applicants should describe:

https://www.cdc.gov/grants/additional-requirements/ar-25.html

Any available baseline measures (including definitions for numerators and denominators used and latest reporting year or timeframe)

Source(s) of data needed to calculate the measures (i.e., which programs or agencies "own" the data)

How useful the measures would be to the applicant How feasible it would be for the applicant to report on the measures Any anticipated barriers to obtaining and calculating the proposed measures Any other comments or questions the applicant has about the proposed measures at this time

Applicants may also propose additional key process, outcome, or performance measures that they plan to collect and track for themselves. Applicants are encouraged to list measures that they believe CDC should consider for inclusion in the final set of common performance measures for this NOFO, either in addition to, or in lieu of, the ones proposed in this NOFO.

Applicants should describe their general approach to conducting evaluation over the period of performance, including:

Their process for identifying and deciding what aspect of their program they will evaluate The specific aspects of their program that they currently consider priorities for evaluation

(with the understanding that this can change over time) Anticipated number of evaluation projects that they believe they can undertake during the

5 year period of performance

c. Organizational Capacity of Recipients to Implement the Approach Applicant must demonstrate abilities and capacity to develop programs with the goal of reducing the incidence of TB in the Philippines and to reduce the tuberculosis burden in US bound populations from the Philippines.

1. Applicant must be able to plan, implement, manage, and evaluate programs related to decreasing the TB Burden in the Philippines.

2. Applicant must demonstrate relevant previous experience and capacity (working with local organizations and ministries of health and the National TB program) to implement the activities and achieve project outcomes. This includes working with programs in all regions of the Philippines in both public and private organizations.

3. Applicant must demonstrate experience developing and implementing specific programs for reducing the TB burden in country.

4. Applicants must have clearly defined roles in order to accomplish tasks related TB reduction programs in the Philippines.

5. Provide evidence of past experience showing they can fully accomplish the proposed activities related to tuberculosis prevention based on methodology, personnel, and requested budget.

6. Demonstrate the ability to plan, implement, manage, and evaluate programs related to diagnosing, managing, and treating infectious tuberculosis.

7. Demonstrate previous experience and the ability to develop and implement specific education programs for diagnosing, managing, and treating infectious tuberculosis.

d. Work Plan Applicant must submit a work plan that covers the first year of the five-year period of performance and a high-level summary of activities for years 2-5.

Proposed strategies must be in alignment with the NOFO logic model.

Required elements in a work plan include strategies and their associated performance measures, as well as major activities and the title of the person/group responsible for each activity.

In this format, the table would be completed for each period of performance outcome. If a particular activity leads to multiple outcomes, it should be described under each outcome measure.

Period of Performance Outcome:

[from Outcomes section and/or logic model]

Outcome Measure:

[from Evaluation and Performance Measurement section]

Strategies and Activities

Process Measure [from Evaluation and Performance Measurement section]

Responsible Position / Party

Completion Date

1.

2.

3.

4.

5.

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and recipients, site visits, and recipient reporting (including work plans, performance, and financial reporting).

Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking recipient progress in achieving the desired outcomes.

Ensuring the adequacy of recipient systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities deemed necessary to monitor the award:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that recipients are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with recipients on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk recipients.

Recipient(s) are expected to work with the project officer and subject matter experts in the Immigrant, Refugee, and Migrant Health Branch in the Division of Global Migration and Quarantine in order to implement activities covered in the NOFO and meet the desired outcomes. They should also collaborate with program to plan for future activities based on the amount of proposed funding for each of the budget periods.

f. CDC Program Support to Recipients

B. Award Information

1. Funding Instrument Type:

CA (Cooperative Agreement) CDC's substantial involvement in this program appears in the CDC Program Support to Recipients Section.

2. Award Mechanism:

U50

3. Fiscal Year:

4. Approximate Total Fiscal Year Funding:

$500,000

5. Total Period of Performance Funding:

$5,000,000 This amount is subject to the availability of funds.

Estimated Total Funding:

$5,000,000

6. Total Period of Performance Length:

5 year(s)

7. Expected Number of Awards:

8. Approximate Average Award:

$1,000,000

Per Budget Period

9. Award Ceiling:

$1,000,000 Per Budget Period

This amount is subject to the availability of funds.

10. Award Floor:

$0 Per Budget Period

11. Estimated Award Date:

August 30, 2022

12. Budget Period Length:

12 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total period of performance comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

13. Direct Assistance Direct Assistance (DA) is not available through this NOFO.

If you are successful and receive a Notice of Award, in accepting the award, you agree that the award and any activities thereunder are subject to all provisions of 45 CFR part 75, currently in effect or implemented during the period of the award, other Department regulations and policies in effect at the time of the award, and applicable statutory provisions.

C. Eligibility Information

1. Eligible Applicants Eligibility Category:

99 (Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility")

25 (Others (see text field entitled "Additional Information on Eligibility" for clarification))

00 (State governments)

01 (County governments)

02 (City or township governments)

04 (Special district governments)

05 (Independent school districts)

06 (Public and State controlled institutions of higher education)

07 (Native American tribal governments (Federally recognized))

23 (Small businesses)

22 (For profit organizations other than small businesses)

20 (Private institutions of higher education)

12 (Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education)

13 (Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education)

11 (Native American tribal organizations (other than Federally recognized tribal governments))

08 (Public housing authorities/Indian housing authorities)

Additional Eligibility Category:

Other

Ministries of Health

2. Additional Information on Eligibility N/A

3. Justification for Less than Maximum Competition N/A

4. Cost Sharing or Matching Cost Sharing / Matching Requirement:

No

5. Maintenance of Effort Maintenance of Effort is not required for this program.

D. Application and Submission Information

1. Required Registrations An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

PLEASE NOTE: For applications due on or after April 4, 2022, applicants must have a unique entity identifier (UEI) at the time of application submission (SF-424, field 8c). In preparation for the federal government’s April 4, 2022 transition to the Unique Entity Identifier (UEI) from the Data Universal Numbering System (DUNS), applicants must obtain a UEI. The UEI is generated as part of SAM.gov registration. Current SAM.gov registrants have already been assigned their UEI and can view it in SAM.gov and grants.gov. Entities registering in SAM.gov prior to April 4, 2022 must still obtain a DUNS number before registering in SAM.gov registration. Additional information is available on the GSA website, SAM.gov, and Grants.gov- Finding the UEI.

https://www.grants.gov/ https://www.gsa.gov/about-us/organization/federal-acquisition-service/office-of-systems-management/integrated-award-environment-iae/iae-systems-information-kit/unique-entity-identifier-update https://sam.gov/content/home https://grantsgovprod.wordpress.com/2021/09/14/how-to-find-an-applicants-uei-within-grants-gov/ https://grantsgovprod.wordpress.com/2021/09/14/how-to-find-an-applicants-uei-within-grants-gov/

a. Data Universal Numbering System:

All applicant organizations must obtain a Data Universal Numbering System (DUNS) number to register in SAM.gov prior to April 4, 2022. A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B).

The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or internet at http:// fedgov.dnb. com/ webform/ displayHomePage.do. The DUNS number will be provided at no charge.

If funds are awarded to an applicant organization that includes sub-recipients, those sub-recipients must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM):

The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as a recipient. All applicant organizations must register with SAM, and will be assigned a SAM number and a Unique Entity Identifier (UEI). All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC.

If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process can require 10 or more business days, and registration must be renewed annually. Additional information about registration procedures may be found at SAM.gov and the SAM.gov Knowledge Base.

c. Grants.gov:

The first step in submitting an application online is registering your organization at www.grants.gov, the official HHS E-grant Web site. Registration information is located at the "Applicant Registration" option at www.grants.gov.

All applicant organizations must register at www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants should start the registration process as early as possible.

StepSystem Requirements Duration Follow Up

Data Universal Number System

(DUNS)

(Required until April 4, 2022)

1. Click on http:// fedgov.dnb.com/ webform

2. Select Begin DUNS search/request process

3. Select your country or territory and follow the instructions to obtain your DUNS 9-digit #

4. Request appropriate staff

1-2 Business Days

To confirm that you have been issued a new DUNS number check online at (http:// fedgov.dnb.com/ webform) or http://fedgov.dnb.com/webform/displayHomePage.do https://sam.gov/content/home https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.fsd.gov%2Fgsafsd_sp%3Fid%3Dgsa_kb_view2%26kb_id%3Df66d8e6cdb76d4100d73f81d0f9619c6&data=04%7C01%7Ccshifflett%40dminc.com%7C8eee7a2adab549a3b3c008d925e9a364%7Cdb7ac9ef779d46e59bca00509580ad6b%7C0%7C0%7C637582507851821018%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=UrR%2B%2FM2wWF2fZG05Z8O6JS2C3FXXSl%2F7B3%2FB45XHRrg%3D&reserved=0 https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.fsd.gov%2Fgsafsd_sp%3Fid%3Dgsa_kb_view2%26kb_id%3Df66d8e6cdb76d4100d73f81d0f9619c6&data=04%7C01%7Ccshifflett%40dminc.com%7C8eee7a2adab549a3b3c008d925e9a364%7Cdb7ac9ef779d46e59bca00509580ad6b%7C0%7C0%7C637582507851821018%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=UrR%2B%2FM2wWF2fZG05Z8O6JS2C3FXXSl%2F7B3%2FB45XHRrg%3D&reserved=0 https://grants.gov/ https://www.grants.gov/ http://www.grants.gov/ https://www.grants.gov/ http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform member(s) to obtain DUNS number, verify & update information under DUNS number call 1-866-705-

System for Award Management

(SAM)

1. Retrieve organizations DUNS number (required until April 4, 2022)

2. Go to SAM.gov and designate an E-Biz POC (You will need to have an active SAM account before you can register on grants.gov). The UEI is generated as part of your registration.

3-5 Business Days but up to 2 weeks and must be renewed once a year

For SAM Customer Service Contact https://fs d.gov/ fsd-gov/ home.do Calls: 86 6-606-8220

3 Grants.gov

1. Set up an individual account in Grants.gov using organization new DUNS number to become an authorized organization representative

(AOR)

2. Once the account is set up the E-BIZ POC will be notified via email

3. Log into grants.gov using the password the E-BIZ POC received and create new password

4. This authorizes the AOR to submit applications on behalf of the organization

Same day but can take 8 weeks to be fully registered and approved in the system (note, applicants MUST obtain a DUNS number and SAM account before applying on grants.gov)

Register early!

Log into grants.gov and check AOR status until it shows you have been approved

2. Request Application Package Applicants may access the application package at www.grants.gov.

3. Application Package Applicants must download the SF-424, Application for Federal Assistance, package associated with this notice of funding opportunity at www.grants.gov.

4. Submission Dates and Times If the application is not submitted by the deadline published in the NOFO, it will not be processed. Office of Grants Services (OGS) personnel will notify the applicant that their application did not meet the deadline. The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant is authorized to submit a paper application, it must be received by the deadline provided by OGS.

a. Letter of Intent Deadline (must be emailed)

The LOI date will generate once the Synopsis is published if Days or a Date are entered.

b. Application Deadline https://sam.gov/content/home https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do

May 2, 2022 11:59 pm U.S. Eastern Standard Time, at www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Due Date for Information Conference Call N/A

5. Pre-Award Assessments Risk Assessment Questionnaire Requirement

CDC is required to conduct pre-award risk assessments to determine the risk an applicant poses to meeting federal programmatic and administrative requirements by taking into account issues such as financial instability, insufficient management systems, non-compliance with award conditions, the charging of unallowable costs, and inexperience. The risk assessment will include an evaluation of the applicant’s CDC Risk Questionnaire, located at https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, as well as a review of the applicant’s history in all available systems; including OMB-designated repositories of government-wide eligibility and financial integrity systems (see 45 CFR 75.205(a)), and other sources of historical information. These systems include, but are not limited to: FAPIIS (https://www.fapiis.gov/), including past performance on federal contracts as per Duncan Hunter National Defense Authorization Act of 2009; Do Not Pay list; and System for Award Management (SAM) exclusions.

CDC requires all applicants to complete the Risk Questionnaire, OMB Control Number 0920- 1132 annually. This questionnaire, which is located at https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, along with supporting documentation must be submitted with your application by the closing date of the Notice of Funding Opportunity Announcement. If your organization has completed CDC’s Risk Questionnaire within the past 12 months of the closing date of this NOFO, then you must submit a copy of that questionnaire, or submit a letter signed by the authorized organization representative to include the original submission date, organization’s EIN and DUNS.

When uploading supporting documentation for the Risk Questionnaire into this application package, clearly label the documents for easy identification of the type of documentation. For example, a copy of Procurement policy submitted in response to the questionnaire may be labeled using the following format: Risk Questionnaire Supporting Documents _ Procurement Policy.

Duplication of Efforts

Applicants are responsible for reporting if this application will result in programmatic, budgetary, or commitment overlap with another application or award (i.e. grant, cooperative agreement, or contract) submitted to another funding source in the same fiscal year. Programmatic overlap occurs when (1) substantially the same project is proposed in more than one application or is submitted to two or more funding sources for review and funding https://www.grants.gov/ https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf consideration or (2) a specific objective and the project design for accomplishing the objective are the same or closely related in two or more applications or awards, regardless of the funding source. Budgetary overlap occurs when duplicate or equivalent budgetary items (e.g., equipment, salaries) are requested in an application but already are provided by another source. Commitment overlap occurs when an individual’s time commitment exceeds 100 percent, whether or not salary support is requested in the application. Overlap, whether programmatic, budgetary, or commitment of an individual’s effort greater than 100 percent, is not permitted. Any overlap will be resolved by the CDC with the applicant and the PD/PI prior to award.

Report Submission: The applicant must upload the report in Grants.gov under “Other Attachment Forms.” The document should be labeled: "Report on Programmatic, Budgetary, and Commitment Overlap.”

6. Content and Form of Application Submission Applicants are required to include all of the following documents with their application package at www.grants.gov.

7. Letter of Intent LOI is not requested or required as part of the application for this NOFO.

8. Table of Contents (There is no page limit. The table of contents is not included in the project narrative page limit.): The applicant must provide, as a separate attachment, the “Table of Contents” for the entire submission package.

Provide a detailed table of contents for the entire submission package that includes all of the documents in the application and headings in the "Project Narrative" section. Name the file "Table of Contents" and upload it as a PDF file under "Other Attachment Forms" at www.grants.gov.

9. Project Abstract Summary A project abstract is included on the mandatory documents list and must be submitted at www.grants.gov. The project abstract must be a self-contained, brief summary of the proposed project including the purpose and outcomes. This summary must not include any proprietary or confidential information. Applicants must enter the summary in the "Project Abstract Summary" text box at www.grants.gov.

10. Project Narrative (Unless specified in the "H. Other Information" section, maximum of 20 pages, single spaced, 12 point font, 1-inch margins, number all pages. This includes the work plan. Content beyond the specified page number will not be reviewed.)

Applicants must submit a Project Narrative with the application forms. Applicants must name this file “Project Narrative” and upload it at www.grants.gov. The Project Narrative must include all of the following headings (including subheadings): Background, Approach, Applicant Evaluation and Performance Measurement Plan, Organizational Capacity of Applicants to Implement the Approach, and Work Plan. The Project Narrative must be succinct, self-explanatory, and in the order outlined in this section. It must address outcomes and activities https://www.grants.gov/ https://www.grants.gov/ https://www.grants.gov/ to be conducted over the entire period of performance as identified in the CDC Project Description section. Applicants should use the federal plain language guidelines and Clear Communication Index to respond to this Notice of Funding Opportunity. Note that recipients should also use these tools when creating public communication materials supported by this NOFO. Failure to follow the guidance and format may negatively impact scoring of the application.

a. Background Applicants must provide a description of relevant background information that includes the context of the problem (See CDC Background).

b. Approach

i. Purpose

Applicants must describe in 2-3 sentences specifically how their application will address the public health problem as described in the CDC Background section.

ii. Outcomes

Applicants must clearly identify the outcomes they expect to achieve by the end of the project period, as identified in the logic model in the Approach section of the CDC Project Description.

Outcomes are the results that the program intends to achieve and usually indicate the intended direction of change (e.g., increase, decrease).

iii. Strategies and Activities

Applicants must provide a clear and concise description of the strategies and activities they will use to achieve the period of performance outcomes. Applicants must select existing evidence-based strategies that meet their needs, or describe in the Applicant Evaluation and Performance Measurement Plan how these strategies will be evaluated over the course of the project period.

See the Strategies and Activities section of the CDC Project Description.

1. Collaborations

Applicants must describe how they will collaborate with programs and organizations either internal or external to CDC. Applicants must address the Collaboration requirements as described in the CDC Project Description.

2. Target Populations and Health Disparities Applicants must describe the specific target population(s) in their jurisdiction and explain how such a target will achieve the goals of the award and/or alleviate health disparities. The applicants must also address how they will include specific populations that can benefit from the program that is described in the Approach section. Applicants must address the Target Populations and Health Disparities requirements as described in the CDC Project Description.

c. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance

Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement. The Paperwork Reduction Act of 1995 (PRA): Applicants are advised that any activities involving information collections (e.g., surveys, questionnaires, applications, audits, data requests, reporting, recordkeeping and disclosure requirements) from 10 or more individuals or non-Federal entities, including State and local governmental agencies, and funded or sponsored by the Federal Government are subject to review and approval by the Office of Management and Budget. For further information about CDC’s requirements under PRA see http://www.hhs.gov/ ocio/policy/collection/.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, data management plan (DMP), and other relevant data information (e.g., performance measures proposed by the applicant).

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan (including the DMP elements) within the first 6 months of award, as described in the Reporting Section of this NOFO.

d. Organizational Capacity of Applicants to Implement the Approach Applicants must address the organizational capacity requirements as described in the CDC Project Description.

11. Work Plan (Included in the Project Narrative’s page limit)

Applicants must prepare a work plan consistent with the CDC Project Description Work Plan section. The work plan integrates and delineates more specifically how the recipient plans to carry out achieving the period of performance outcomes, strategies and activities, evaluation and performance measurement.

12. Budget Narrative Applicants must submit an itemized budget narrative. When developing the budget narrative, applicants must consider whether the proposed budget is reasonable and consistent with the purpose, outcomes, and program strategy outlined in the project narrative. The budget must include:

http://www.hhs.gov/ocio/policy/collection/

Salaries and wages

Fringe benefits

Consultant costs

Equipment

Supplies

Travel

Other categories

Contractual costs

Total Direct costs

Total Indirect costs

Indirect costs could include the cost of collecting, managing, sharing and preserving data.

Indirect costs on grants awarded to foreign organizations and foreign public entities and performed fully outside of the territorial limits of the U.S. may be paid to support the costs of compliance with federal requirements at a fixed rate of eight percent of MTDC exclusive of tuition and related fees, direct expenditures for equipment, and subawards in excess of $25,000. Negotiated indirect costs may be paid to the American University, Beirut, and the World Health Organization.

If applicable and consistent with the cited statutory authority for this announcement, applicant entities may use funds for activities as they relate to the intent of this NOFO to meet national standards or seek health department accreditation through the Public Health Accreditation Board (see: http://www.phaboard.org). Applicant entities to whom this provision applies include state, local, territorial governments (including the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau), or their bona fide agents, political subdivisions of states (in consultation with states), federally recognized or state-recognized American Indian or Alaska Native tribal governments, and American Indian or Alaska Native tribally designated organizations. Activities include those that enable a public health organization to deliver public health services such as activities that ensure a capable and qualified workforce, up-to-date information systems, and the capability to assess and respond to public health needs. Use of these funds must focus on achieving a minimum of one national standard that supports the intent of the NOFO. Proposed activities must be included in the budget narrative and must indicate which standards will be addressed.

Vital records data, including births and deaths, are used to inform public health program and policy decisions. If applicable and consistent with the cited statutory authority for this NOFO, applicant entities are encouraged to collaborate with and…

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated .